Costi David Sifri, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

Harvard Medical School - Boston MA
Rank: Instructor
Years: 2002-2004

University Of Virginia School Of Medicine - Charlottesville VA
Rank: Full Professor
Years: 2004 - present

None Reported

First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States
J Clin Microbiol
Volume: 51
Date: 02 2013
www.ncbi.nlm.nih.gov/pubmed/23175248

Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012
Infect Control Hosp Epidemiol
Volume: 35
Date: 06 2014
www.ncbi.nlm.nih.gov/pubmed/24915208

Preparedness planning and care of patients under investigation for or with Ebola virus disease: A survey of physicians in North America
Am J Infect Control
Volume: 45
Date: 01 2017

Diagnostic stewardship for healthcare-associated infections: Opportunities and challenges to safely reduce test use
Infect Control Hosp Epidemiol
Volume: 39
Date: 02 2018

Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients
Transpl Infect Dis
Volume: 20
Date: 06 2018

Intensive care unit wastewater interventions to prevent transmission of multispecies Klebsiella pneumoniae carbapenemase-producing organisms
Clin Infect Dis
Volume: 67
Date: 06 2018